CF-PPiD technology based on cell-free protein array and proximity biotinylation enzyme for in vitro direct interactome analysis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
22 06 2022
Historique:
received: 19 03 2022
accepted: 14 06 2022
entrez: 22 6 2022
pubmed: 23 6 2022
medline: 25 6 2022
Statut: epublish

Résumé

Protein-protein interaction (PPI) analysis is a key process to understand protein functions. Recently, we constructed a human protein array (20 K human protein beads array) consisting of 19,712 recombinant human proteins produced by a wheat cell-free protein production system. Here, we developed a cell-free protein array technology for proximity biotinylation-based PPI identification (CF-PPiD). The proximity biotinylation enzyme AirID-fused TP53 and -IκBα proteins each biotinylated specific interacting proteins on a 1536-well magnetic plate. In addition, AirID-fused cereblon was shown to have drug-inducible PPIs using CF-PPiD. Using the human protein beads array with AirID-IκBα, 132 proteins were biotinylated, and then selected clones showed these biological interactions in cells. Although ZBTB9 was not immunoprecipitated, it was highly biotinylated by AirID-IκBα, suggesting that this system detected weak interactions. These results indicated that CF-PPiD is useful for the biochemical identification of directly interacting proteins.

Identifiants

pubmed: 35732899
doi: 10.1038/s41598-022-14872-w
pii: 10.1038/s41598-022-14872-w
pmc: PMC9217950
doi:

Substances chimiques

Recombinant Proteins 0
NF-KappaB Inhibitor alpha 139874-52-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10592

Informations de copyright

© 2022. The Author(s).

Références

Cancer Res. 1997 Sep 1;57(17):3693-6
pubmed: 9288775
Biochem Biophys Res Commun. 2022 Feb 12;592:54-59
pubmed: 35030423
Genes Dev. 2012 Feb 1;26(3):203-34
pubmed: 22302935
Biochem J. 1986 Jul 1;237(1):123-30
pubmed: 3800873
PLoS One. 2016 Jun 01;11(6):e0156718
pubmed: 27249653
Nat Methods. 2008 Dec;5(12):1011-7
pubmed: 19054851
Mol Endocrinol. 2010 May;24(5):914-22
pubmed: 20304996
Cold Spring Harb Perspect Biol. 2012 Mar 01;4(3):
pubmed: 22296764
Parasit Vectors. 2017 Oct 30;10(1):536
pubmed: 29084576
Nat Commun. 2020 Sep 14;11(1):4578
pubmed: 32929090
J Cell Biol. 2012 Mar 19;196(6):801-10
pubmed: 22412018
J Biol Chem. 2004 Dec 10;279(50):52175-82
pubmed: 15469940
BMC Plant Biol. 2015 Nov 10;15:275
pubmed: 26556605
Anal Chem. 2004 Apr 1;76(7):1844-9
pubmed: 15053642
Mol Cell Proteomics. 2017 Dec;16(12):2199-2218
pubmed: 28982715
Plant Mol Biol. 2009 Mar;69(4):473-88
pubmed: 19083153
Methods Mol Biol. 2015;1278:341-52
pubmed: 25859960
Nat Commun. 2017 Oct 17;8(1):1004
pubmed: 29042542
Protein Sci. 2004 Nov;13(11):3043-50
pubmed: 15459338
Genes Dev. 1992 Oct;6(10):1899-913
pubmed: 1340770
PLoS One. 2015 Jun 15;10(6):e0129226
pubmed: 26075596
Trends Biochem Sci. 2005 Jan;30(1):43-52
pubmed: 15653325
Science. 2014 Jan 17;343(6168):301-5
pubmed: 24292625
Front Chem. 2021 Oct 07;9:718405
pubmed: 34692637
Nat Rev Drug Discov. 2019 Dec;18(12):949-963
pubmed: 31666732
Nat Rev Cancer. 2004 Apr;4(4):314-22
pubmed: 15057291
Nat Commun. 2020 Jun 19;11(1):3133
pubmed: 32561764
Nat Immunol. 2002 Mar;3(3):221-7
pubmed: 11875461
Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6045-50
pubmed: 18420815
Front Immunol. 2016 Sep 22;7:378
pubmed: 27713747
FEBS Lett. 2014 Mar 3;588(5):659-64
pubmed: 24457201
Signal Transduct Target Ther. 2019 Dec 24;4:64
pubmed: 31885879
Immunol Rev. 2012 Mar;246(1):193-204
pubmed: 22435556
J Biol Chem. 1983 May 25;258(10):6660-4
pubmed: 6406485
J Biol Chem. 2019 Sep 20;294(38):14135-14148
pubmed: 31366726
Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):E2453-61
pubmed: 24927568
Nat Rev Drug Discov. 2006 Apr;5(4):310-20
pubmed: 16582876
DNA Res. 2008 Jun 30;15(3):137-49
pubmed: 18316326
Sci Rep. 2019 Dec 18;9(1):19349
pubmed: 31852950
EMBO J. 2021 Mar 15;40(6):e104296
pubmed: 33459422
Chem Biol. 2015 Jun 18;22(6):755-63
pubmed: 26051217
PLoS One. 2016 Jun 06;11(6):e0156716
pubmed: 27271343
Nat Biotechnol. 2018 Oct;36(9):880-887
pubmed: 30125270
Science. 2014 Jan 17;343(6168):305-9
pubmed: 24292623
Science. 2001 Sep 14;293(5537):2101-5
pubmed: 11474067
EMBO J. 2002 Sep 2;21(17):4491-9
pubmed: 12198151
Sci Rep. 2016 Oct 20;6:35631
pubmed: 27762338
Nat Chem Biol. 2018 Oct;14(10):981-987
pubmed: 30190590
Nature. 1997 May 15;387(6630):296-9
pubmed: 9153395
Elife. 2020 May 11;9:
pubmed: 32391793
Science. 2010 Mar 12;327(5971):1345-50
pubmed: 20223979
Cell. 1998 Dec 11;95(6):729-31
pubmed: 9865689
J Biol Chem. 1995 Jan 13;270(2):815-22
pubmed: 7822316

Auteurs

Shusei Sugiyama (S)

CellFree Sciences. Co. Ltd., 3 Bunkyo-cho, Matsuyama, Ehime, 790-8577, Japan.

Kohdai Yamada (K)

Proteo-Science Center, 3 Bunkyo-cho, Matsuyama, Ehime, 790-8577, Japan.

Miwako Denda (M)

CellFree Sciences. Co. Ltd., 3 Bunkyo-cho, Matsuyama, Ehime, 790-8577, Japan.

Satoshi Yamanaka (S)

Proteo-Science Center, 3 Bunkyo-cho, Matsuyama, Ehime, 790-8577, Japan.

Satoshi Ozawa (S)

CellFree Sciences. Co. Ltd., 3 Bunkyo-cho, Matsuyama, Ehime, 790-8577, Japan.

Ryo Morishita (R)

CellFree Sciences. Co. Ltd., 3 Bunkyo-cho, Matsuyama, Ehime, 790-8577, Japan. rmorishita@cfsciences.com.

Tatsuya Sawasaki (T)

Proteo-Science Center, 3 Bunkyo-cho, Matsuyama, Ehime, 790-8577, Japan. sawasaki@ehime-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH